Corey N. Fishman Insider Trading $ITRM Iterum Therapeutics plc
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Corey N. Fishman.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Corey N. Fishman. Corey N. Fishman is Director in BIOSPECIFICS TECHNOLOGIES CORP ($BSTCE) and Director in MOMENTA PHARMACEUTICALS INC ($MNTA) and COO & CFO in Durata Therapeutics, Inc. ($DRTX) and President & CEO in Iterum Therapeutics plc ($ITRM).
Corey N. Fishman in Iterum Therapeutics plc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Corey N. Fishman: President & CEO
Holdings: 407,453 shares
Latest Transaction: Mar 15 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Corey N. Fishman in Iterum Therapeutics plc
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BSTCE, DRTX, ITRM, MNTA
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 15 2021 | ITRM | Iterum Therapeutic ... | Fishman Corey N. | President & CEO | Option Exercise | A | 0.00 | 430,000 | 0 | 430,000 | |
| Jan 27 2021 | ITRM | Iterum Therapeutic ... | Fishman Corey N. | President & CEO | Sell | S | 1.73 | 85,445 | 147,820 | 322,008 | 407.5 K to 322 K (-20.97 %) |
| Jan 27 2021 | ITRM | Iterum Therapeutic ... | Fishman Corey N. | President & CEO | Grant | A | 0.00 | 167,500 | 0 | 407,453 | 240 K to 407.5 K (+69.81 %) |
| Feb 19 2019 | ITRM | Iterum Therapeutic ... | Fishman Corey N. | President & CEO | Option Exercise | A | 5.80 | 150,000 | 870,000 | 150,000 | |
| Aug 21 2018 | ITRM | Iterum Therapeutic ... | Fishman Corey N. | President & CEO | Buy | P | 8.73 | 2,000 | 17,466 | 239,953 | 238 K to 240 K (+0.84 %) |
| Aug 21 2018 | ITRM | Iterum Therapeutic ... | Fishman Corey N. | President & CEO | Buy | P | 8.73 | 2,000 | 17,466 | 239,953 | 238 K to 240 K (+0.84 %) |
| May 30 2018 | ITRM | Iterum Therapeutic ... | Fishman Corey N. | President & CEO | Option Exercise | C | 0.00 | 1,591 | 0 | 0 | |
| May 30 2018 | ITRM | Iterum Therapeutic ... | Fishman Corey N. | President & CEO | Option Exercise | C | 0.00 | 4,050 | 0 | 0 | |
| May 30 2018 | ITRM | Iterum Therapeutic ... | Fishman Corey N. | President & CEO | Option Exercise | C | 0.00 | 33,259 | 0 | 0 | |
| May 30 2018 | ITRM | Iterum Therapeutic ... | Fishman Corey N. | President & CEO | Buy | P | 13.00 | 3,000 | 39,000 | 237,953 | 235 K to 238 K (+1.28 %) |
| May 30 2018 | ITRM | Iterum Therapeutic ... | Fishman Corey N. | President & CEO | Buy | C | 0.00 | 1,591 | 0 | 234,953 | 233.4 K to 235 K (+0.68 %) |
| May 30 2018 | ITRM | Iterum Therapeutic ... | Fishman Corey N. | President & CEO | Buy | C | 0.00 | 4,050 | 0 | 233,362 | 229.3 K to 233.4 K (+1.77 %) |
| May 30 2018 | ITRM | Iterum Therapeutic ... | Fishman Corey N. | President & CEO | Buy | C | 0.00 | 33,259 | 0 | 229,312 | 196.1 K to 229.3 K (+16.96 %) |
| May 29 2018 | ITRM | Iterum Therapeutic ... | Fishman Corey N. | President & CEO | Option Exercise | A | 13.00 | 127,307 | 1,654,991 | 127,307 |
Page: 1